Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pressure Group Undaunted By EU Refusal To Disclose COVID-19 Vaccine Contracts

Corporate Europe Observatory Cites Overriding Public Interest

Executive Summary

The European Commission has dismissed attempts by pressure groups to secure access to details of COVID-19 vaccine deals negotiated with pharmaceutical firms. The Corporate Europe Observatory says it is “disappointed” by the decision but is not giving up the chase.

You may also be interested in...



EU Committee To Discuss Future COVID-19 Vaccine Purchasing Deals

The health commissioner and three member state health ministers will take part in a debate on how advance purchase agreements were drawn up during the pandemic, and how they should be handled in future health crises.

Coronavirus Notebook: EU Publishes CureVac Vaccine Contract, AZ and Pfizer Under Attack Over Supply Cuts

The European Ombudsman has opened an inquiry regarding the disclosure of vaccine contracts with other companies, and the European Commission is planning a “sharing mechanism” for vaccines bought by EU member states.

EU May Disclose Some Details Of COVID-19 Vaccine Contracts

The European Commission seems to be prepared to disclose some parts of the contracts it is signing with companies for coronavirus vaccines, but transparency campaigners say this might not be enough to engender trust in the vaccines among the population at large. 

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS143237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel